[go: up one dir, main page]

ZA884622B - Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance - Google Patents

Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance

Info

Publication number
ZA884622B
ZA884622B ZA884622A ZA884622A ZA884622B ZA 884622 B ZA884622 B ZA 884622B ZA 884622 A ZA884622 A ZA 884622A ZA 884622 A ZA884622 A ZA 884622A ZA 884622 B ZA884622 B ZA 884622B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical
pellets
substance
controlled release
pharmaceutical compositions
Prior art date
Application number
ZA884622A
Other languages
English (en)
Inventor
Horst-Georg Zerbe
Zerbe Horst-Georg
Jorn Ullrich Beckewr
Ullrich Beckewr Jorn
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of ZA884622B publication Critical patent/ZA884622B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1664Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA884622A 1987-06-30 1988-06-28 Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance ZA884622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873721574 DE3721574A1 (de) 1987-06-30 1987-06-30 Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung

Publications (1)

Publication Number Publication Date
ZA884622B true ZA884622B (en) 1990-02-28

Family

ID=6330589

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884622A ZA884622B (en) 1987-06-30 1988-06-28 Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance

Country Status (7)

Country Link
EP (1) EP0370049A1 (xx)
JP (1) JPH02504145A (xx)
AU (1) AU618748B2 (xx)
DE (1) DE3721574A1 (xx)
NZ (1) NZ225158A (xx)
WO (1) WO1989000045A1 (xx)
ZA (1) ZA884622B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049395A (en) * 1989-03-09 1991-09-17 Micro Vesicular Systems, Inc. Controlled release vehicle
SE8901279D0 (sv) * 1989-04-10 1989-04-10 Pharmacia Ab Komposition
DE3918801A1 (de) * 1989-06-06 1991-05-08 Schmidt Walter Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
NL9201196A (nl) * 1992-07-03 1994-02-01 Tno Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.
NL9201195A (nl) * 1992-07-03 1994-02-01 Tno Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.
ES2086949T3 (es) * 1992-07-24 1996-07-01 Labopharm Inc Material polihidroxilico reticulado para liberacion de farmaco enzimaticamente controlada.
EP0675739A1 (en) * 1992-12-28 1995-10-11 BAUSCH & LOMB INCORPORATED Controlled release composition for active substances into an aqueous medium
CA2378265C (en) * 1999-08-09 2007-11-20 Dainippon Pharmaceutical Co., Ltd. Solid preparations containing chitosan powder and process for producing the same
WO2001037811A1 (en) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
FR2938433B1 (fr) * 2008-11-19 2011-09-09 Francois Fauran Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation
JP6069782B2 (ja) * 2012-11-09 2017-02-01 国立大学法人佐賀大学 基質応答性自律振動型マイクロカプセル
CN113172887B (zh) * 2021-03-15 2023-04-07 中国科学院上海硅酸盐研究所 一种具有缓释功能的同轴支架材料

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4261969A (en) * 1979-05-03 1981-04-14 World Health Organization Controlled drug release composition
DE2923279C2 (de) * 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
JPS5640151A (en) * 1979-09-06 1981-04-16 Daiichi Seiyaku Co Coating device for tablet
WO1983003061A1 (en) * 1982-03-04 1983-09-15 Battelle Development Corp Dual microcapsules
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom

Also Published As

Publication number Publication date
JPH02504145A (ja) 1990-11-29
AU2124588A (en) 1989-01-30
DE3721574A1 (de) 1989-01-12
EP0370049A1 (en) 1990-05-30
WO1989000045A1 (en) 1989-01-12
NZ225158A (en) 1990-12-21
AU618748B2 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
EP0251459A3 (en) Controlled release pharmaceutical composition
GB2204792B (en) Pharmaceutical composition
PT83508A (en) Process for the preparation of pharmaceutical compositions with controlled release
HUT46028A (en) Process for producing pharmaceutical compositions containing oligosaccharides as active components and for producing the active components
ZA889495B (en) Sustained release pharmaceutical composition
EP0326618A4 (en) MEDICAL COMPOSITION, WHICH CONTAINS ALBUMIN AS A CARRIER, AND METHOD FOR THE PRODUCTION THEREOF.
JPS6413076A (en) Novel compound, manufacture and medicinal composition
ZA883167B (en) Pharmaceutical composition
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
GB8810765D0 (en) Pharmaceutical composition
ZA874899B (en) Controlled release dosage form comprising acetaminophen,pseudeophedrine and dexbrompheniramine
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
HUT42292A (en) Insecticidal compositions comprising fluorbenzyl esters as active substance and process for preparing the active substances
JPS6413088A (en) Novel compound, manufacture and medicinal composition
IL77322A (en) Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof
JPS6479146A (en) Drug composition
HUT41398A (en) Insecticidal compositions comprising tetrazolyl derivatives as active substance and process for preparing the active substances
IL87563A0 (en) Isoxazole-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
IL84659A0 (en) Pharmaceutical composition comprising azumolene
JPS6468379A (en) Novel compound, its production and pharmaceutical composition containing the same
GB2211091B (en) Polyester-based composition for the controlled release of medicinal substances
HUT42679A (en) Insecticidal and acaricidal compositions comprising alkanoyl-anilide derivatives as active substance and process for preparing the active substances
GB2184726B (en) Azoniaspironortropanol esters, processes for the preparation thereof and pharmaceutical compositions containing them
JPS6442470A (en) Guanidinecarboxylic acid esters, manufacture and medicinal composition